Amneal Pharmaceuticals, Inc. Class A Common Stock Strategic Asset Allocation Index
Amneal Pharmaceuticals, Inc. Class A Common Stock strategic asset allocation index. Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Strategic Asset Allocation Index of 251.1% as of June 2023. Strategic assets (PP&E of $459.11 Million plus long-term investments of $-) total $459.11 Million, measured against net assets of $182.87 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See AMRX net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Amneal Pharmaceuticals, Inc. Class A Common Stock (2018–2022)
Strategic asset allocation index of Amneal Pharmaceuticals, Inc. Class A Common Stock from 2018 to 2022. This chart shows how Amneal Pharmaceuticals, Inc. Class A Common Stock's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of June 2023, the index stands at 251.1%, representing strategic assets of $459.11 Million against net assets of $182.87 Million USD. Check Amneal Pharmaceuticals, Inc. Class A Com (AMRX) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Amneal Pharmaceuticals, Inc. Class A Common Stock Strategic Asset Allocation Index by Year (2018–2022)
Amneal Pharmaceuticals, Inc. Class A Common Stock strategic asset allocation index by year from 2018 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Amneal Pharmaceuticals, Inc. Class A Common Stock from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Amneal Pharmaceuticals, Inc. Class A Com worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 224.9% | $469.81 Million | $469.81 Million | $- | $208.93 Million | ▲ +84.8 pp |
| 2021 | 140.1% | $514.16 Million | $514.16 Million | $- | $366.97 Million | ▲ +1.6 pp |
| 2020 | 138.5% | $477.75 Million | $477.75 Million | $- | $344.93 Million | ▼ -45.2 pp |
| 2019 | 183.7% | $636.97 Million | $620.60 Million | $16.37 Million | $346.79 Million | ▲ +123.0 pp |
| 2018 | 60.7% | $544.15 Million | $544.15 Million | $- | $896.36 Million | — |